Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clearblue Connects Peak Fertility Data To Smartphone App

Executive Summary

P&G's connected Clearblue tracks a user’s personal hormone profile and sends data to a smartphone, typically alerting on the four or more best days to get pregnant, providing a window into fertility two days longer than other ovulation testing brands, the firm says.

You may also be interested in...



OTC Contraceptive App Has US Approval As Claims Are Scrutinized In Sweden, UK

UK authority advises Natural Cycles Nordic to discontinue an ad claim its contraceptive app is “highly accurate” because it is not based on "typical" use. Sweden is investigating the firm due to the app's failure rate, but in the US, FDA recently approved it.

OTC Contraceptive App Has US Approval As Claims Are Scrutinized In Sweden, UK

UK authority advises Natural Cycles Nordic to discontinue an ad claim its contraceptive app is “highly accurate” because it is not based on "typical" use. Sweden is investigating the firm due to the app's failure rate, but in the US, FDA recently approved it.

Smartphone Apps Appropriate For OTC Product Instructions – Consultant

“The present has passed us by” in using appropriate technology to provide consumers more information than on US Drug Facts labels, Pinney Associates’ Saul Shiffman says at CPHA conference.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121989

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel